Startup

Gliapharm

Description

Gliapharm is a biotech startup based in Geneva, Switzerland, dedicated to reimagining brain health by focusing on the role of glial cells in brain function and health. Their team of experts is leveraging decades of research to develop new drugs targeting glia-mediated pathways for neuroprotection and cognitive function maintenance in patients with challenging neurological and psychiatric disorders. By stimulating energy utilization in the brain through astrocytes, Gliapharm aims to address brain hypometabolism, a core feature of various neurological conditions.

About this result
This page is automatically generated and may contain information that is not correct, complete, up-to-date, or relevant to your search query. The same applies to every other page on this website. Please make sure to verify the information with EPFL's official sources.